Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity
Swaak, A.
Journal of Rheumatology 33(8): 1467-1468
2006
ISSN/ISBN: 0315-162X PMID: 16881103 Document Number: 595921
Document emailed within 1 workday
Related Documents
Mule, A.; Sirohi, P.; Ram, N. 2018: Prevalence of Chronic Liver Disease Among the Patients of Celiac Disease and Effect of Gluten-Free Diet on Outcome of Liver Disease: a Prospective Study Journal of the Association of Physicians of India 66(3): 34-36Durmus, B.; Altay, Z.; Baysal, O.; Ersoy, Y.; Erdal, A.; Cevik, R.; Ardicoglu, O.; Tekeoglu, I.; Yildirim, K.; Sarac, A.J.; Kamanli, A.; Karatay, S.; Nas, K.; Kaya, A.; Senel, K.; Gur, A.; Ugur, M.; Ozgocmen, S. 2011: Can the patient-reported outcome instruments determine disease activity in rheumatoid arthritis? Bratislavske Lekarske Listy 112(10): 555-561
Krause, D.; Gabriel, B.; Herborn, G.; Braun, J.; Rau, R. 2014: The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline Clinical and Experimental Rheumatology 32(3): 395-400
Chen, J.R.; Takahashi, M.; Suzuki, M.; Kushida, K.; Miyamoto, S.; Inoue, T. 1998: Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis Journal of Rheumatology 25(12): 2440-2444
Hanly, J.G.; Mosher, D.; Sutton, E.; Weerasinghe, S.; Theriault, D. 1996: Self-assessment of disease activity by patients with rheumatoid arthritis Journal of Rheumatology 23(9): 1531-1538
Van Herwaarden, N.; Herfkens-Hol, S.; van der Maas, A.; van den Bemt, B.J.F.; van Vollenhoven, R.F.; Bijlsma, J.W.J.; den Broeder, A.A. 2014: Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity Clinical and Experimental Rheumatology 32(3): 390-394
Lassere, M.N.; van der Heijde, D.; Johnson, K.R.; Boers, M.; Edmonds, J. 2001: Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials Journal of Rheumatology 28(4): 892-903
Kamper, E.F.; Kopeikina, L.T.; Trontzas, P.; Potamianou, A.; Tsiroglou, E.; Stavridis, J.C. 2000: The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis Journal of Rheumatology 27(11): 2545-2550
El-Maghraby, H.M.; Rabie, R.A.; Makram, W.K. 2019: Correlation between Relative Expression of IL 17 and PERP in Rheumatoid Arthritis Patients and Disease Activity Egyptian Journal of Immunology 26(2): 19-29
Youinou, P.Y.; Le Goff, P.; Morrow, W.J.; Miossec, P.; Pennec, Y. 1983: Analysis of lymphocyte subsets in the blood of rheumatoid arthritis patients: correlation with disease activity Journal of Rheumatology 10(5): 708-712
Louthrenoo, W.; Kongtawelert, P.; Sivasomboon, C.; Sukitawut, W. 2001: Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis Journal of the Medical Association of Thailand 84(5): 622-627
Wacharapornin, P.; Suwannalai, P. 2014: Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs Journal of the Medical Association of Thailand 97(11): 1157-1163
Brun, J.G.; Haga, H.J.; Bøe, E.; Kallay, I.; Lekven, C.; Berntzen, H.B.; Fagerhol, M.K. 1992: Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity Journal of Rheumatology 19(6): 859-862
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Yildirim, K.; Karatay, S.; Melikoglu, M.Alkan.; Gureser, G.; Ugur, M.; Senel, K. 2005: Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Annals of Clinical and Laboratory Science 34(4): 423-426
Cortet, B.; Flipo, R.M.; Blanckaert, F.; Duquesnoy, B.; Marchandise, X.; Delcambre, B. 1997: Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy Revue du Rhumatisme 64(7-9): 451-458
Sarosiek, J.; Badurski 1978: The excretion of proteins and carbohydrates in gastric juice in patients with chronic rheumatoid arthritis not complicated by ulcerative disease Przeglad Lekarski 35(3): 349-354
Geboes, K.; Desreumaux, P.; Jouret, A.; Ectors, N.; Rutgeerts, P.; Colombel, J.F. 1999: Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. use of histological scores Gastroenterologie Clinique et Biologique 23(10): 1062-1073
García-Bermúdez, M.; González-Juanatey, C.; Rodríguez-Rodríguez, L.; Vazquez-Rodriguez, T.R.; Miranda-Filloy, J.A.; Fernández-Gutierrez, B.; Llorca, J.; Martin, J.; González-Gay, M.A. 2011: Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 29(2): 293-298
Rooney, M.; Whelan, A.; Feighery, C.; Bresnihan, B. 1989: The immunohistologic features of synovitis, disease activity and in vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis Journal of Rheumatology 16(4): 459-467